Indalo Therapeutics

Indalo Therapeutics develops novel treatments for fibrotic diseases. Their biotechnology platform offers cutting-edge insights into the molecular drivers of aberrant scarring, enabling fibrotic patients to improve their lives with therapies that arrest or reverse their fibrosis.

Argonautic Ventures Special Situations Fund I SP (AVSS I) & Argonautic iSelect Special Situations Fund I SP (AISS)